India, March 10 -- The global pharmaceutical industry is putting up a good fight against antimicrobial resistance (AMR). However, drug resistance is outpacing industry-wide efforts.

The challenge therefore is to urgently develop and apply approaches across more products and across more countries to mimimise the global threat of AMR and save lives, according to the 2026 AMR Benchmark report brought out by the Access to Medicine Foundation based in Amsterdam, the Netherlands.

More than one million people die each year as a direct result of drug-resistant infections, while AMR contributes to over four million deaths in total. By 2050, direct and indirect deaths are projected to rise to nearly two million and more than eight million, respec...